North Carolina women who are considering breast augmentation procedures may be interested to learn that there have been nine reported deaths from a rare form of cancer that has been associated with breast implants. The Food and Drug Administration stated that women who had breast implants had a low risk of developing this particular cancer, though the risk was increased when compared to women who did not have breast implants.
The extremely rare cancer is known as anaplastic large cell lymphoma. Although it is not a form of breast cancer, it can be found around the breast implants, in the skin or in the lymph nodes. As of Feb. 1, 2017, the FDA had received a total of 359 reports of cancer that could possibly be caused by breast implants. However, it was noted that the number of cases was difficult to estimate due to limitations in implant sales data and reporting.
The FDA first raised awareness about the increased risk in 2011. Since then, more information about the risks have become available. Based on the available reports, women who received implants that have textured surfaces were more likely to be diagnosed with ALCL. Even so, the risks are still very low with less than 10 patients being diagnosed with cancer every year.
If it is found that a product such as breast implants cause cancer or other adverse health conditions, people who have been harmed may have the grounds to file a products liability lawsuit against the manufacturer. An attorney may provide evidence that supports the claims, including reports from the FDA and medical records. Victims could seek compensation for the damages they incurred, such as the costs for treatment of the cancer or other medical conditions directly caused by the defective product.